Importantly, pharmacological or genetic inhibition of autophagy restores tamoxifen sensitivity, indicating that autophagy inhibitory strategies could be considered for tamoxifen resistant, high MTA1 expressing breast cancer [145]. Here, MTA1 is linked to breast carcinoma.